Medical device recalls Moderate risk

Horiba Instruments Inc recalls ABX PENTRA Enzymatic Creatinine CP ref. A11A01907 reagent is intended for the quantitative in vitro diagnostic determin…

Recall date
January 11, 2016
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-0739-2016
FDA classification
Class II
Brand / firm
Horiba Instruments Inc
Sold / distributed
U.S. distribution to the following; CA, NY, AL, OK, MN, MS, MD, TX, KY, WV, MT, IL, FL, VA, WA, MI, KS, NE, PA, OH, ID, OR, AR, AZ, NM, NC, SC, GA, TN No foreign distribution.

Why it was recalled

N-Acetylcysteine (NAC) present in the blood of patients treated for paracetamol overdose can interfere with the Trinder reaction that uses hydrogen peroxide catalytic on aminoantipyrine and phenol, and can produce falsely low results with the reagents using the Trinder reaction method.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

ABX PENTRA Enzymatic Creatinine CP ref. A11A01907 reagent is intended for the quantitative in vitro diagnostic determination of creatinine in human serum, plasma and urine based on an enzymatic method of using a multi-step approach ending with a photometric end-point reaction.

Get recall alerts

Free email alert whenever Horiba Instruments Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Horiba Instruments Inc